Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

Phuong Tran; Sang‑Eun Lee; Dong‑Hyun Kim; Yong‑Chul Pyo; Jeong‑Sook Park

Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

Recommendations

Search

Type: Academic journal

Author: Phuong Tran Sang‑Eun Lee Dong‑Hyun Kim Yong‑Chul Pyo Jeong‑Sook Park

Journal: Korean Society of Pharmaceutical Science and Technology Journal of Pharmaceutical Investigation Journal of Pharmaceutical Investigation 제50권 제3호 KCI Accredited Journals

Published: 2020.1

Pages: 261 - 270 (10page)

Usage

Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

Abstract· Keywords

Report Errors

Background Breast cancer is one of the most common causes of death for women worldwide. While chemotherapy is the treatment option for most cancers, surgery, chemotherapy, and radiotherapy are the three main therapeutic strategies for the treatment of breast cancer. In recent years, nanotechnology applications for cancer treatments have attracted a lot of attention. Area covered This review focuses on the various nanoparticle types, such as liposomes, micelles, polymeric nanoparticles, solid lipid nanoparticles, and gold nanoparticles, and their applications for the treatment of breast cancer. Expert opinion In recent decades, nanotechnology has developed and been applied to cancer treatments. Currently, nanotechnology plays an important role in the targeted delivery of drugs for cancer treatments, including breast cancer. Nanoparticles can target tumors and control the release of drugs to precise sites, thereby improving the therapeutic efficiency of drugs and decreasing the toxicity to normal tissues or organs. In addition, nanoparticles are also able to activate immune cells against tumors. Therefore, nanoparticles are a promising tool for future cancer research and treatment.

No content found

References (66)

Add References

American Cancer Society I / 2018 / Cancer facts & figures 2018. Atlanta: American Cancer Society / BMJ 309:1689

Anders CK / 2013 / Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer / PLoS ONE 8:e61359

Arvizo R / 2010 / Gold nanoparticles : opportunities and challenges in nanomedicine / Expert Opin Drug Deliv 7:753~763

Bangham AD / 1964 / Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope / J Mol Biol 8:660

Batrakova EV / 2001 / Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers : selective energy depletion / Br J Cancer 85:1987~1997

Recommendations

It is an article recommended by DBpia according to the article similarity. Check out the related articles!